calcium channel, voltage-dependent, L type, alpha 1E subunit |
PIPAMAZINE |
Calcium Channel Type L, Benzothiazepine |
60% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
PIPAMAZINE |
Calcium Channel Type L, Benzothiazepine |
60% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
PIPAMAZINE |
Calcium Channel Type L, Benzothiazepine |
60% |
NoneNone |
NoneNone |
View
|
Protein-tyrosine kinase, Fyn |
PIPAMAZINE |
Protein Tyrosine Kinase, Fyn |
60% |
NoneNone |
NoneNone |
View
|
Sigma-2 Receptor |
ECONAZOLE |
Sigma2 |
60% |
5.157uM |
3.174uM |
View
|
monoamine oxidase A |
4-AMINO-1,8-NAPHTHALIMIDE |
Monoamine Oxidase MAOA |
60% |
NoneNone |
NoneNone |
View
|
monoamine oxidase A |
4-AMINO-1,8-NAPHTHALIMIDE |
Monoamine Oxidase MAOA |
60% |
NoneNone |
NoneNone |
View
|
histamine receptor H 2 |
KETOCONAZOLE |
Histamine H2 |
60% |
21.872uM |
21.507uM |
View
|
aldo-keto reductase family 1, member B4 (aldose reductase) |
ZAPRINAST |
Aldose Reductase |
60% |
NoneNone |
NoneNone |
View
|
aldo-keto reductase family 1, member B1 (aldose reductase) |
ZAPRINAST |
Aldose Reductase |
60% |
NoneNone |
NoneNone |
View
|
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) |
ZAPRINAST |
Aldose Reductase |
60% |
NoneNone |
NoneNone |
View
|
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) |
ZAPRINAST |
Aldose Reductase |
60% |
NoneNone |
NoneNone |
View
|
Protein-tyrosine kinase, Fyn |
BENZO[A]PYRENE |
Protein Tyrosine Kinase, Fyn |
60% |
26.235uM |
NoneNone |
View
|
opioid receptor, delta 1 |
CIGLITAZONE |
Opiate delta |
60% |
26.894uM |
9.481uM |
View
|
Cytochrom P450-2D6 monooxygenase |
Y-27632 |
CYP450-2D6 Inhibition |
60% |
NoneNone |
NoneNone |
View
|
arginine vasopressin receptor 1A |
DIETHYLSTILBESTROL |
Vasopressin V1A |
60% |
25.925uM |
10.401uM |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Benzothiazepine |
60% |
21.12uM |
18.77uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Benzothiazepine |
60% |
21.12uM |
18.77uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Benzothiazepine |
60% |
21.12uM |
18.77uM |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Benzothiazepine |
60% |
21.12uM |
18.77uM |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Benzothiazepine |
60% |
21.12uM |
18.77uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Benzothiazepine |
60% |
21.12uM |
18.77uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Benzothiazepine |
60% |
21.12uM |
18.77uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Benzothiazepine |
60% |
21.12uM |
18.77uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Benzothiazepine |
60% |
21.12uM |
18.77uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Benzothiazepine |
60% |
21.12uM |
18.77uM |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
TRIHEXYPHENIDYL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Benzothiazepine |
60% |
21.12uM |
18.77uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Benzothiazepine |
60% |
21.12uM |
18.77uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Benzothiazepine |
60% |
21.12uM |
18.77uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Benzothiazepine |
60% |
21.12uM |
18.77uM |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Benzothiazepine |
60% |
21.12uM |
18.77uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Benzothiazepine |
60% |
21.12uM |
18.77uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Benzothiazepine |
60% |
21.12uM |
18.77uM |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Benzothiazepine |
60% |
21.12uM |
18.77uM |
View
|
potassium voltage-gated channel, subfamily H, member 8 |
PYRILAMINE |
Potassium Channel HERG |
60% |
12.6182uM |
10.3378uM |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 6 |
PYRILAMINE |
Potassium Channel HERG |
60% |
12.6182uM |
10.3378uM |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 7 |
PYRILAMINE |
Potassium Channel HERG |
60% |
12.6182uM |
10.3378uM |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
PYRILAMINE |
Potassium Channel HERG |
60% |
12.6182uM |
10.3378uM |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 5 |
PYRILAMINE |
Potassium Channel HERG |
60% |
12.6182uM |
10.3378uM |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 3 |
PYRILAMINE |
Potassium Channel HERG |
60% |
12.6182uM |
10.3378uM |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 4 |
PYRILAMINE |
Potassium Channel HERG |
60% |
12.6182uM |
10.3378uM |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 1 |
PYRILAMINE |
Potassium Channel HERG |
60% |
12.6182uM |
10.3378uM |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 1 |
PYRILAMINE |
Potassium Channel HERG |
60% |
12.6182uM |
10.3378uM |
View
|
cytochrome P450, family 3, subfamily a, polypeptide 13 |
RIFABUTIN |
CYP450-3A4 Inhibition |
60% |
NoneNone |
NoneNone |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
TRANS-PLATINUM(II)DIAMMINE DICHLORIDE |
Protein Tyrosine Kinase, HER2 Receptor |
60% |
NoneNone |
NoneNone |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
TRANS-PLATINUM(II)DIAMMINE DICHLORIDE |
Protein Tyrosine Kinase, HER2 Receptor |
60% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 3, subfamily a, polypeptide 13 |
PROPAFENONE |
CYP450-3A4 Inhibition |
60% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 |
VINDESINE |
Thromboxane Synthetase |
60% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
VINDESINE |
Thromboxane Synthetase |
60% |
NoneNone |
NoneNone |
View
|
Sigma-2 Receptor |
DESLORATADINE |
Sigma2 |
60% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 1A |
DOMPERIDONE |
Serotonin 5-HT1A |
60% |
NoneNone |
NoneNone |
View
|
lymphocyte protein tyrosine kinase (mapped) |
MONTELUKAST |
Protein Tyrosine Kinase, Lck |
60% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 3, subfamily a, polypeptide 13 |
OXYBUTYNIN |
CYP450-3A4 Inhibition |
60% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 3, subfamily a, polypeptide 13 |
ANASTROZOLE |
CYP450-3A4 Inhibition |
60% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 3, subfamily a, polypeptide 13 |
METERGOLINE |
CYP450-3A4 Inhibition |
60% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2a |
BUFLOMEDIL |
Adrenergic alpha2A |
60% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage gated, type VIII, alpha |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VII, alpha |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, beta |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, alpha |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, alpha |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, beta |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, alpha 2 |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, beta |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, alpha |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 |
ALPHA-ERGOCRYPTINE |
Thromboxane Synthetase |
60% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
ALPHA-ERGOCRYPTINE |
Thromboxane Synthetase |
60% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, beta |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
sodium channel associated protein 1 |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
sodium channel associated protein 2 |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, beta |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, alpha |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IX, alpha |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VII, alpha |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
amiloride-sensitive cation channel 5, intestinal |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
FLUPHENAZINE |
Calcium Channel Type L, Dihydropyridine |
59% |
29.304uM |
18.838uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
FLUPHENAZINE |
Calcium Channel Type L, Dihydropyridine |
59% |
29.304uM |
18.838uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
FLUPHENAZINE |
Calcium Channel Type L, Dihydropyridine |
59% |
29.304uM |
18.838uM |
View
|
Cytochrom P450-1A2 monooxygenase |
CAFFEIC ACID PHENETHYL ESTER |
CYP450-1A2 Inhibition |
59% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 1 |
MEFENAMIC ACID |
Protein Serine/Threonine Kinase, ERK2 |
59% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 1 |
MEFENAMIC ACID |
Protein Serine/Threonine Kinase, ERK2 |
59% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2b |
LABETALOL |
Adrenergic alpha2B |
59% |
NoneNone |
NoneNone |
View
|
mu-opioid receptor MOR |
LABETALOL |
Opiate mu |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
LABETALOL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
LABETALOL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
LABETALOL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
LABETALOL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
LABETALOL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
LABETALOL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
LABETALOL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
LABETALOL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
LABETALOL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
LABETALOL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
LABETALOL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
LABETALOL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
LABETALOL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
LABETALOL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
LABETALOL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2a |
BW-723C86 |
Adrenergic alpha2A |
59% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
SULOCTIDIL |
Serotonin 5-HT2C |
59% |
NoneNone |
NoneNone |
View
|
lymphocyte protein tyrosine kinase (mapped) |
ZINC CHLORIDE |
Protein Tyrosine Kinase, Lck |
59% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-2D6 monooxygenase |
BUPROPION |
CYP450-2D6 Inhibition |
59% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 14 |
CHROMIUM(III) CHLORIDE |
Protein Serine/Threonine Kinase, p38alpha |
59% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 14 |
CHROMIUM(III) CHLORIDE |
Protein Serine/Threonine Kinase, p38alpha |
59% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2a |
CINNARIZINE |
Imidazoline I2, Central |
59% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
CINNARIZINE |
Imidazoline I2, Central |
59% |
NoneNone |
NoneNone |
View
|
cholecystokinin A receptor |
DOMPERIDONE |
Cholecystokinin CCKA |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
METHAPYRILENE |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
METHAPYRILENE |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
METHAPYRILENE |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
METHAPYRILENE |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
METHAPYRILENE |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
METHAPYRILENE |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
METHAPYRILENE |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
METHAPYRILENE |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
METHAPYRILENE |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
METHAPYRILENE |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
METHAPYRILENE |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
METHAPYRILENE |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
METHAPYRILENE |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
METHAPYRILENE |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
METHAPYRILENE |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
METHAPYRILENE |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
METHAPYRILENE |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
METHAPYRILENE |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, beta |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VIII, alpha polypeptide |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type XI, alpha |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, beta |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type 10, alpha polypeptide |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, alpha polypeptide |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type V, alpha polypeptide |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, beta |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 alpha |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 gamma |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 beta |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type XI, alpha |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1, gamma |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1, delta |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 alpha |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase VB, mitochondrial |
ISONIAZID |
Carbonic Anhydrase |
9% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type X, alpha |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IX, alpha |
ALPHA-ERGOCRYPTINE |
Sodium Channel, Site 2 |
60% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 2 |
BERBERINE CHLORIDE |
Muscarinic M2 |
60% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
DIPHENIDOL |
Serotonin 5-HT2B |
60% |
NoneNone |
NoneNone |
View
|
opioid receptor, kappa 1 |
CLOSANTEL |
Opiate kappa |
60% |
NoneNone |
NoneNone |
View
|
sodium channel associated protein 2 |
PHENTOLAMINE |
Sodium Channel, Site 2 |
59% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, beta |
PHENTOLAMINE |
Sodium Channel, Site 2 |
59% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, alpha |
PHENTOLAMINE |
Sodium Channel, Site 2 |
59% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IX, alpha |
PHENTOLAMINE |
Sodium Channel, Site 2 |
59% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 4A, cAMP specific |
NISOLDIPINE |
Phosphodiesterase PDE4 |
59% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 4C, cAMP-specific |
NISOLDIPINE |
Phosphodiesterase PDE4 |
59% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 4D |
NISOLDIPINE |
Phosphodiesterase PDE4 |
59% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 4B, cAMP specific |
NISOLDIPINE |
Phosphodiesterase PDE4 |
59% |
NoneNone |
NoneNone |
View
|
tachykinin receptor 1 |
ASTEMIZOLE |
Tachykinin NK1 |
59% |
15.793uM |
8.615uM |
View
|
androgen receptor |
SULFASALAZINE |
Testosterone |
59% |
43.951uM |
29.301uM |
View
|
opioid receptor, sigma 1 |
DROPERIDOL |
Sigma1 |
59% |
NoneNone |
NoneNone |
View
|
opioid receptor, kappa 1 |
DROPERIDOL |
Opiate kappa |
59% |
NoneNone |
NoneNone |
View
|
opioid receptor, delta 1 |
HALOPROGIN |
Opiate delta |
59% |
NoneNone |
NoneNone |
View
|
adenosine A2a receptor |
HALOPROGIN |
Adenosine A2A |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
TRIHEXYPHENIDYL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
TRIHEXYPHENIDYL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
TRIHEXYPHENIDYL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
TRIHEXYPHENIDYL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
TRIHEXYPHENIDYL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
TRIHEXYPHENIDYL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
TRIHEXYPHENIDYL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
TRIHEXYPHENIDYL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
TRIHEXYPHENIDYL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
TRIHEXYPHENIDYL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
TRIHEXYPHENIDYL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
TRIHEXYPHENIDYL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
TRIHEXYPHENIDYL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
TRIHEXYPHENIDYL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
TRIHEXYPHENIDYL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
TRIHEXYPHENIDYL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
TRIHEXYPHENIDYL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
TRIHEXYPHENIDYL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
TRIHEXYPHENIDYL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
TRIOXSALEN |
Serotonin 5-HT2B |
59% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 3B |
TROGLITAZONE |
Phosphodiesterase PDE3 |
59% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 3A |
TROGLITAZONE |
Phosphodiesterase PDE3 |
59% |
NoneNone |
NoneNone |
View
|
epidermal growth factor receptor |
HALOPROGIN |
Protein Tyrosine Kinase, EGF Receptor |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
LABETALOL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
LABETALOL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
LABETALOL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
LABETALOL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase XII |
ISONIAZID |
Carbonic Anhydrase |
9% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
LABETALOL |
Calcium Channel Type L, Phenylalkylamine |
59% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-2D6 monooxygenase |
R-(+)-PROPRANOLOL |
CYP450-2D6 Inhibition |
59% |
NoneNone |
NoneNone |
View
|
dopamine receptor D3 |
ISOTRETINOIN |
Dopamine D3 |
59% |
NoneNone |
NoneNone |
View
|
dopamine receptor D3 |
EPERISONE |
Dopamine D3 |
59% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 5B |
BROMOCRIPTINE |
Serotonin 5-HT4 |
59% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 4 |
BROMOCRIPTINE |
Serotonin 5-HT4 |
59% |
NoneNone |
NoneNone |
View
|
Sigma-2 Receptor |
CITALOPRAM |
Sigma2 |
59% |
NoneNone |
NoneNone |
View
|
androgen receptor |
1-NAPHTHYL ISOTHIOCYANATE |
Testosterone |
59% |
25.513uM |
17.009uM |
View
|